Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1975 Nov;12(5):1051–1057. doi: 10.1128/iai.12.5.1051-1057.1975

In vivo and in vitro stimulation of mouse spleen leukocytes by BL-20803, a low-molecular-weight interferon inducer.

P Siminoff
PMCID: PMC415396  PMID: 1193723

Abstract

BL-20803, a low-molecular-weight compound, although able to elicit circulating interferon in the mouse, failed to protect cultured cell lines in vitro from infection by interferon-sensitive viruses. Of the tissues analyzed for interferon content after oral administration of the drug to mice, spleen and lung contained the largest amounts of the virus inhibitor. Spleen cells from such dosed animals when isolated into in vitro cultures elaborated small amounts of interferon into the culture medium. The time sequence of acquisition by spleen cells of the ability to produce interferon closely correlated with the kinetics of development of the circulating interferon response in the intact mouse. When spleen cells were separated on the basis of adherence or nonadherence to a plastic surface, the bulk of the interferon activity was found to be associated with the adherent cells. Upon exposure to BL-20803 in cell culture, adherent cells and, to a lesser extent, nonadherent cells from untreated mice were stimulated to produce interferon-like activity. The biological behavior of BL-20803 is shown to have striking similarities with that of the structurally different low-molecular-weight inducer tilorone hydrochloride.

Full text

PDF
1051

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acton J. D. The lymphoreticular system and interferon production. J Reticuloendothel Soc. 1973 Nov;14(5):449–461. [PubMed] [Google Scholar]
  2. De Clercq E., Merigan T. C. Bis-DEAE-fluorenone: mechanism of antiviral protection and stimulation of interferon production in the mouse. J Infect Dis. 1971 Feb;123(2):190–199. doi: 10.1093/infdis/123.2.190. [DOI] [PubMed] [Google Scholar]
  3. De Somer P., De Clercq E., Billiau A., Schonne E., Claesen M. Antiviral activity of polyacrylic and polymethacrylic acids. II. Mode of action in vivo. J Virol. 1968 Sep;2(9):886–893. doi: 10.1128/jvi.2.9.886-893.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dennis A. J., Wilson H. E., Barker A. D., Rheins M. S. Interferon induction in normal leukemic human lymphocyte cultures by tilorone hydrochloride. Proc Soc Exp Biol Med. 1972 Dec;141(3):782–785. doi: 10.3181/00379727-141-36870. [DOI] [PubMed] [Google Scholar]
  5. Falcoff E., Falcoff R., Eyquem A., Sanceau J., Catinot L., de Vomecourt A. Induction d'interféron humain par le sérum antilymphocytaire. C R Acad Sci Hebd Seances Acad Sci D. 1970 Aug 3;271(5):545–548. [PubMed] [Google Scholar]
  6. Hoffman W. W., Korst J. J., Niblack J. F., Cronin T. H. N,N-dioctadecyl-N',N'-bis(2-hydroxyethyl) propanediamine: antiviral activity and interferon stimulation in mice. Antimicrob Agents Chemother. 1973 Apr;3(4):498–502. doi: 10.1128/aac.3.4.498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ito Y., Nagata I., Kunii A. Mechanism of endotoxin-type interferon production in mice. Virology. 1973 Apr;52(2):439–446. doi: 10.1016/0042-6822(73)90339-5. [DOI] [PubMed] [Google Scholar]
  8. KONO Y., HO M. THE ROLE OF THE RETICULOENDOTHELIAL SYSTEM IN INTERFERON FORMATION IN THE RABBIT. Virology. 1965 Jan;25:163–166. doi: 10.1016/0042-6822(65)90268-0. [DOI] [PubMed] [Google Scholar]
  9. Krueger R. E., Mayer G. D. Tilorone hydrochloride: an orally active antiviral agent. Science. 1970 Sep 18;169(3951):1213–1214. doi: 10.1126/science.169.3951.1213. [DOI] [PubMed] [Google Scholar]
  10. Oie H. K., Buckler C. E., Uhlendorf C. P., Hill D. A., Baron S. Improved assays for a variety of interferons. 1. Proc Soc Exp Biol Med. 1972 Sep;140(4):1178–1181. doi: 10.3181/00379727-140-36636. [DOI] [PubMed] [Google Scholar]
  11. Osborn J. E., Walker D. L. The role of individual spleen cells in the interferon response of the intact mouse. Proc Natl Acad Sci U S A. 1969 Apr;62(4):1038–1045. doi: 10.1073/pnas.62.4.1038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rohovsky M. W., Newberne J. W., Gibson J. P. Effects of an oral interferon-inducer on the hematopoietic and reticuloendothelial systems. Toxicol Appl Pharmacol. 1970 Sep;17(2):556–558. doi: 10.1016/0041-008x(70)90215-2. [DOI] [PubMed] [Google Scholar]
  13. STINEBRING W. R., YOUNGNER J. S. PATTERNS OF INTERFERON APPEARANCE IN MICE INFECTED WITH BACTERIA OR BACTERIAL ENDOTOXIN. Nature. 1964 Nov 14;204:712–712. doi: 10.1038/204712a0. [DOI] [PubMed] [Google Scholar]
  14. Siminoff P., Bernard A. M., Hursky V. S., Price K. E. BL-20803, a new, low-molecular-weight interferon inducer. Antimicrob Agents Chemother. 1973 Jun;3(6):742–743. doi: 10.1128/aac.3.6.742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Soehner R. L., Gambardella M. M., Hou E. F., Pollard M. Oral induction of interferon by a low-molecular-weight compound. Proc Soc Exp Biol Med. 1974 Mar;145(3):1114–1119. doi: 10.3181/00379727-145-37963. [DOI] [PubMed] [Google Scholar]
  16. Stringfellow D. A., Glasgow L. A. Tilorone hydrochloride: an oral interferon-inducing agent. Antimicrob Agents Chemother. 1972 Aug;2(2):73–78. doi: 10.1128/aac.2.2.73. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES